Target intelligence / Profile preview

Solute carrier family 37 member 3 (SLC37A3)

Target
SLC37A3
Molecular classification
Transporter, Member of the solute carrier (SLC) superfamily, Sugar-phosphate/phosphate exchanger family (SLC37)
01

Overview

Solute carrier family 37 member 3 (SLC37A3) is an endoplasmic reticulum-associated membrane protein belonging to the SLC37 family of sugar-phosphate exchangers. It shares moderate sequence similarity with other SLC37 family members but remains uniquely uncharacterized in terms of its exact transport activity or physiological substrate. SLC37A3 is expressed highly in murine neutrophils and pancreas, and is also present in liver, kidney, intestine, and macrophages, suggesting potential roles in immune function and metabolism. Although mutations in the gene have been observed in a case of congenital hyperinsulinism of infancy, its physiological and pathological functions have not been confirmed and no clear disease mechanism has been established. No drugs or inhibitory compounds are currently known to target this protein directly, and there are no clinical biomarkers or safety concerns described for this transporter.

Other names
Sugar phosphate exchanger 3SPX3Solute carrier family 37, member 3Sugar-phosphate exchange protein 3DKFZp761N0624
02

Mechanism of action

Not established (Mechanistic data lacking due to unknown functional transport activity)

03

Biological functions

Unknown (Function not yet determined; presumed to be involved in sugar-phosphate exchange across intracellular membranes, likely endoplasmic reticulum)Possible role in the immune system and pancreas, inferred from its expression pattern
04

Disease associations

Variants have been linked to congenital hyperinsulinism of infancy (possible association, but unconfirmed functional role)Possible involvement in obesity-related metabolic dysfunction (epigenetic changes observed with changes in metabolic state)
05

Safety considerations

None described (Therapeutic targeting and associated safety concerns are not addressed in the literature)
06

Interacting drugs

None known (No known small molecules or drugs currently reported to interact with SLC37A3 specifically)
07

Biomarkers

None established (SLC37A3 is not a validated biomarker for patient selection or monitoring)

Beyond the preview

Go deeper on Solute carrier family 37 member 3 (SLC37A3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 37 member 3 (SLC37A3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call